Showing results (31-40 of 109) with videos related to
Sort By:
Pageof 11
Acta Neurochirurgica. Supplement|October 15, 2015
Assessment of the Correlations Between Brain Weight and Brain Edema in Experimental Subarachnoid HemorrhageYu Hasegawa, Hidenori Suzuki, Takashi Nakagawa, et al.American Journal of Hypertension|August 31, 2016
Transient Mild Cerebral Ischemia Significantly Deteriorated Cognitive Impairment in a Mouse Model of Alzheimer's Disease via Angiotensin AT1 ReceptorTakashi Nakagawa, Yu Hasegawa, Ken Uekawa, et al.Circulation|March 8, 2006
Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complicationsVijay Koka, Wansheng Wang, Xiao Ru Huang, et al.Translational Stroke Research|November 22, 2019
The Stabilization of Central Sympathetic Nerve Activation by Renal Denervation Prevents Cerebral Vasospasm after Subarachnoid Hemorrhage in RatsYushin Takemoto, Yu Hasegawa, Kenyu Hayashi, et al.Cardiovascular Diabetology|December 3, 2017
DPP-4 inhibition with linagliptin ameliorates the progression of premature aging in klotho-/- miceYu Hasegawa, Kenyu Hayashi, Yushin Takemoto, et al.Cardiovascular Diabetology|May 20, 2015
DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic miceMingJie Ma, Yu Hasegawa, Nobutaka Koibuchi, et al.Journal of Alzheimer'S Disease : JAD|April 30, 2016
Intracerebroventricular Infusion of Angiotensin-(1-7) Ameliorates Cognitive Impairment and Memory Dysfunction in a Mouse Model of Alzheimer's DiseaseKen Uekawa, Yu Hasegawa, Satoru Senju, et al.Experimental Gerontology|February 21, 2019
Continuous intracerebroventricular injection of Porphyromonas gingivalis lipopolysaccharide induces systemic organ dysfunction in a mouse model of Alzheimer's diseaseKenyu Hayashi, Yu Hasegawa, Yushin Takemoto, et al.American Journal of Hypertension|March 13, 2015
LCZ696, Angiotensin II Receptor-Neprilysin Inhibitor, Ameliorates High-Salt-Induced Hypertension and Cardiovascular Injury More Than Valsartan AloneHiroaki Kusaka, Daisuke Sueta, Nobutaka Koibuchi, et al.Journal of Hypertension|October 30, 2009
Potentiation by candesartan of protective effects of pioglitazone against type 2 diabetic cardiovascular and renal complications in obese miceMasaya Fukuda, Taishi Nakamura, Keiichiro Kataoka, et al.Pageof 11